FENBENDAZOLE Oral Dewormer

Manufacturer
Shenzhen Zhenshangzekai Technology Co., Ltd.
Effective date
2026-03-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:50:55

Label at a glance#

ProductFENBENDAZOLE Oral Dewormer
Active ingredientFENBENDAZOLE
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Febendazole

INACTIVE INGREDIENT SECTION

Glycerin, Magnesium Aluminum Silicate, Sodium Carboxymethylcellulose, Sorbitol, and Purified

Water.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

OTHER SAFETY INFORMATION

The antiparasitic efficacy is achieved through the systematic inhibition of energy metabolism

within the target parasites.

DOSAGE & ADMINISTRATION SECTION

Standard Therapeutic Dose:
2.3 mg/lb(5 mg/kg) of body weight.
Intensive Care Dose:
4.6 mg/lb(10 mg/kg) for specific larval stages or young animals.
Calibration Instructions:
1.Accurately assess the animal's weight prior to administration.
2. Remove the protective tip and rotate the dial ring to the zero position.
3. Advance the dial ring to the graduation corresponding to the measured weight.
4. Ensure the oral cavity is clear of food particles.
5. Administer the paste onto the back of the tongue by depressing the plunger firmly.
Yield: One 25g syringe provides a complete dose for a 1,100 lb animal at the standard 5 mg/kg
rate.

OTC - PURPOSE SECTION

dewormer

WARNINGS SECTION

Human Safety: NOT FOR USE IN HUMANS.
· Food Safety: Do not use in animals intended for human consumption.
· Animal Care: Safety in pregnant animals or breeding stallions at the 10 mg/kg dosage for 5
days has not been specifically evaluated.
· Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.
Resistance Management:
Fecal examinations and diagnostic monitoring are recommended to maintain long-term efficacy
and manage parasite resistance.
Environmental & Storage Conditions:
· Store at or below 25°C (77℉) in a temperature-controlled environment.
· Keep the syringe tightly capped when not in use.

INDICATIONS & USAGE SECTION

Indicated for the clinical management of:
Large Strongyles: (Strongylus edentatus, S. equinus, S. vulgaris).
Small Strongyles: Including various larval stages (encysted early 3rd stage, late 3rd stage, and 4th
stage cyathostome larvae).
Ascarids / Roundworms: (Parascaris equorum).
Pinworms: (Oxyuris equi).

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

horsehorse

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130716921720742GTIN-13: 0716921720742
EAN-13: 0716921720742
GTIN-12: 716921720742
UPC-A: 716921720742
GTIN storage (14 digits): 00716921720742
horse1.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87276-263-00FENBENDAZOLE Oral Dewormer1 g in 1 TUBEPASTE12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87276-26387276-263-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4d720a5b-f344-d25a-e063-6294a90abd6d4d34fc06-35ff-0a6e-e063-6394a90aa9c02026-03-20WarningsExact identifier
spl id: 4d720a5b-f344-d25a-e063-6294a90abd6d
spl set id: 4d34fc06-35ff-0a6e-e063-6394a90aa9c0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.